|4HW -- Germany Stock|| |
EUR 0.30 0.015 4.70%
Dr. Daniele Pieraccioli Ph.D. serves as Director of Intellectual Property at Molecular Medicine S.p.A. since December 2007. He is Qualified European Patent Attorney with scientific background in Medicinal Chemistry and Biotechnology and is responsible for managing all aspects of intellectual property including evaluation of patentability patent prosecution and freedom to operate through validityinfringement opinions. He has international experience with pharmaceutical and biotech companies including GlaxoSmithKline and Serono. He was Research Scientist for a few years before his professional involvement in the intellectual property. He was involved in the patentee side in patent infringement proceedings on blockbuster drugs as well as in EPO proceedings and litigations in Europe on biotechnological products with final positive outcome of the proceedings. He is Speaker at both national and international Conferences and Author of publications in the field of Intellectual Property. He gained a degree in Chemistry from Universita degli Studi di Firenze and gained a Doctorate in Philosophy from Eidgenossische Technische Hochschule Zurich.
Age: 65 Director Since 2007 Ph.D
39 02 21 27 71 http://www.molmed.com
The company has return on total asset (ROA)
of (11.32) %
which means that it has lost $11.32 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (25.93) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 964 K in total debt with debt to equity ratio (D/E) of 3.9 implying the company greatly relies on financing operations through barroing. MolMed S p A has Current Ratio of 1.94 which is within standard range for the sector.
MolMed S.p.A., a medical biotechnology company, focuses on the research, development, and clinical validation of anticancer therapies. MolMed S.p.A. was founded in 1996 and is headquartered in Milan, Italy. MolMed S operates under Biotechnology classification in Germany and traded on Frankfurt Stock Exchange.MolMed S p A (4HW) is traded on Frankfurt Stock Exchange in Germany. It is located in Via Olgettina, 58 and employs 23 people.
MolMed S p Leadership Team
|Gian Rizzardi, Director Research & Development|
|Marina Bue, General Manager of Business Development and Administration, Executive Director|
|Didier Trono, Independent Director|
|Silvia Pisante, Head of Legal Affairs & Corporate Governance|
|Mario Masciocchi, Lead Independent Director|
|Carlo Incerti, Independent Director|
|Raffaella Ruggiero, Independent Director|
|Holger Neecke, Director Business Development & Investor Relations|
|Luca Alberici, Head of Business Development|
|Maurizio Tassi, Non-Executive Director|
|Daniele Pieraccioli, Director Intellectual Property|
|Alberto Carletti, Non-Executive Director|
|Laura Ferro, Independent Director|
|Marco Dieci, Director Special Projects|
|Catia Traversari, Director Research|
|Lorenzo Salieri, Director|
|Elizabeth Robinson, Independent Director|
|Riccardo Palmisano, CEO|
|Sabina Grossi, Non-Executive Director|
|Alfredo Messina, Non-Executive Director|
|Monica Masolo, Independent Director|
|Germano Carganico, General Manager of Research & Development and Operations|
|Claudio Bordignon, Chairman of the Board, CEO|
|Gianluigi Fiorendi, Non-Independent Non-Executive Director|
|Andrea Quaglino, Director Administration Finance & Control|
|Khalid Islam, Non-Executive Non-Independent Director|
|Laura Villa, Director of Investor Relations & Communication|
|Cynthia Giuliani, Director of Human Resources|
|Antonio Lambiase, Director Clinical Development|
|Marco Manoni, Director Operations|
|Tiziano Andreoli, Director of Information Technology|
Stock Performance Indicators
Macroaxis portfolio users are unresponsive in their sentiment towards investing in MolMed S p A. What is your trading attitude regarding investing in MolMed S p A? Are you bullish or bearish?
Check also Trending Equities
. Please also try My Watchlist Analysis
module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.